Page 62 - 《南京医科大学学报（自然科学版）》2025年第9期

第45卷第9期
·1274 · 南 京 医 科 大 学 学 报 2025年9月

［9］ HAN Y Q，WANG J Y，SUN T，et al. Predictive biomarkers 5706-5717
of response and survival following immunotherapy with a ［22］ XU L L，LIU N H，ZHAN W J，et al. Granzyme B turns
PD ⁃ L1 inhibitor benmelstobart（TQB2450）and antian⁃ nanoparticle fluorescence“on”for imaging cytotoxic T
giogenic therapy with a VEGFR inhibitor anlotinib for lymphocyte activity in vivo［J］. ACS Nano，2022，16（11）：
pretreated advanced triple negative breast cancer［J］. 19328-19334
Signal Transduct Target Ther，2023，8（1）：429 ［23］LI X X，CHEN G Y，WU K C，et al. Imaging and monitor⁃
［10］ GIBNEY G T，WEINER L M，ATKINS M B. Predictive ing of granzyme B in the immune response［J］. Wiley
biomarkers for checkpoint inhibitor⁃based immunotherapy Interdiscip Rev Nanomed Nanobiotechnol，2024，16（1）：
［J］. Lancet Oncol，2016，17（12）：e542-e551 e1928
［11］LIU Z Y，LI Z. Molecular imaging in tracking tumor⁃spe⁃ ［24］LARIMER B M，WEHRENBERG⁃KLEE E，DUBOIS F，
cific cytotoxic T lymphocytes（CTLs）［J］. Theranostics， et al. Granzyme B PET imaging as a predictive biomarker
2014，4（10）：990-1001 of immunotherapy response［J］. Cancer Res，2017，77
［12］MAC Q D，MATHEWS D V，KAHLA J A，et al. Non⁃inva⁃ （9）：2318-2327
sive early detection of acute transplant rejection via nano⁃ ［25］LARIMER B M，BLOCH E，NESTI S，et al. The effective⁃
sensors of granzyme B activity［J］. Nat Biomed Eng， ness of checkpoint inhibitor combinations and administra⁃
2019，3（4）：281-291 tion timing can be measured by granzyme B PET imag⁃
［13］WEGRZYNIAK O，LECHI F，MITRAN B，et al. Non⁃ ing［J］. Clin Cancer Res，2019，25（4）：1196-1205
invasive PET imaging of liver fibrogenesis using a RESCA⁃ ［26］ ZHANG Y J，DESHANE J S，YANG E S，et al. A novel
conjugated Affibody molecule［J］. iScience，2024，27（5）： translational PET imaging approach to quantifying distal
109688 tumor immune activation after targeted radiation therapy
［14］PILKINGTON P，LOPCI E，ADAM J A，et al. FDG⁃PET/ and checkpoint blockade［J］. Int J Radiat Oncol Biol
CT variants and pitfalls in haematological malignancies Phys，2024，118（5）：1217-1227
［J］. Semin Nucl Med，2021，51（6）：554-571 ［27］ CAPACCIONE K M，DOUBROVIN M，BHATT N，et al.
［15］DECAZES P，BOHN P. Immunotherapy by immune check⁃ Granzyme B PET imaging of the innate immune response
point inhibitors and nuclear medicine imaging：current ［J］. Molecules，2020，25（13）：3102
and future applications［J］. Cancers（Basel），2020，12 ［28］ ZHOU H Y，WANG Y P，XU H C，et al. Noninvasive
+
（2）：371 interrogation of CD8 T cell effector function for monitor⁃
［16］BENSCH F，VAN DER VEEN E L，LUB⁃DE HOOGE M ing early tumor responses to immunotherapy［J］. J Clin
N，et al. 89 Zr⁃atezolizumab imaging as a non⁃invasive Invest，2022，132（16）：e161065
approach to assess clinical response to PD ⁃L1 blockade ［29］ ABBASI GHARIBKANDI N，CONLON J M，HOSSEIN⁃
in cancer［J］. Nat Med，2018，24（12）：1852-1858 IMEHR S J. Strategies for improving stability and phar⁃
［17］WEI W J，JIANG D W，EHLERDING E B，et al. Noninva⁃ macokinetic characteristics of radiolabeled peptides for
sive PET imaging of T cells［J］. Trends Cancer，2018，4 imaging and therapy［J］. Peptides，2020，133：170385
（5）：359-373 ［30］ XU H C，WEI Z X，CHEN B X，et al. Granzyme B PET
［18］ RASHIDIAN M，INGRAM J R，DOUGAN M，et al. Pre⁃ imaging inflammation and remodeling in myocardial
dicting the response to CTLA⁃4 blockade by longitudinal infarction［J］. Eur J Nucl Med Mol Imaging，2024，51
noninvasive monitoring of CD8 T cells［J］. J Exp Med， （4）：991-1001
68
2017，214（8）：2243-2255 ［31］SHEN X L，ZHOU H Y，ZHOU X，et al. Ga⁃grazytracer
［19］HACKL H，CHAROENTONG P，FINOTELLO F，et al. PET for noninvasive assessment of response to immuno⁃
Computational genomics tools for dissecting tumour ⁃ im⁃ therapy in solid tumors and lymphomas：a phase 1/2 clini⁃
mune cell interactions［J］. Nat Rev Genet，2016，17（8）： cal trial［J］. Nat Commun，2024，15（1）：8791
441-458 ［32］LIU Q F，XU X P，YANG Z Y，et al. Granzyme B PET/CT
［20］NOBASHI T W，MAYER A T，XIAO Z Y，et al. Whole⁃ imaging evaluates early response to immunotherapy in
body PET imaging of T⁃cell response to glioblastoma［J］. gastric cancer［J］. J Nucl Med，2024，65（11）：1695-
Clin Cancer Res，2021，27（23）：6445-6456 1701
［21］GIBSON H M，MCKNIGHT B N，MALYSA A，et al. IFNγ ［33］JIANG C J，TIAN Q W，XU X P，et al. Enhanced antitu⁃
131
PET imaging as a predictive tool for monitoring response mor immune responses via a new agent［ I］⁃ labeled
to tumor immunotherapy［J］. Cancer Res，2018，78（19）： dual⁃target immunosuppressant［J］. Eur J Nucl Med Mol